Suchergebnisse - "Dogné, Jean-Michel"

PubPharm (170)

1

Kinetics and ability of binding antibody and surrogate virus neutralization tests to predict neutralizing antibodies against the SARS-CoV-2 Omicron variant following BNT162b2 booster administration

enthalten in: Clinical chemistry and laboratory medicine | 2023

von Simon, G. | Favresse, J. | Gillot, C. | +6

2

Peri-infection titers of neutralizing and binding antibodies as a predictor of COVID-19 breakthrough infections in vaccinated healthcare professionals: importance of the timing

enthalten in: Clinical chemistry and laboratory medicine | 2023

von Gillot, C. | Bayart, J. | Closset, M. | +5

3

Assessment of the humoral response in Omicron breakthrough cases in healthcare workers who received the BNT162b2 booster

enthalten in: Clinical chemistry and laboratory medicine | 2022

von Favresse, J. | Dogné, J. | Douxfils, J.

4

Spike vs. nucleocapsid serum antigens for COVID-19 diagnosis and severity assessment

enthalten in: Clinical chemistry and laboratory medicine | 2022

von Favresse, J. | Bayart, J. | David, C. | +4

5

Authors’ Reply to Braillon and Martin’s Comment on “Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)”

enthalten in: Drug safety | 2021

von Bahri, P. | Morales, D. | Inoubli, A. | +2

6

Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients

enthalten in: Clinical chemistry and laboratory medicine | 2020

von Favresse, J. | Elsen, M. | Eucher, C. | +6

7

Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment Using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)

enthalten in: Drug safety | 2020

von Bahri, P. | Morales, D. | Inoubli, A. | +2

8

Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose Optimization

enthalten in: European journal of drug metabolism and pharmacokinetics | 2020

von Thémans, P. | Belkhir, L. | Dauby, N. | +14

9

Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study

enthalten in: Clinical chemistry and laboratory medicine | 2020

von Favresse, J. | Eucher, C. | Elsen, M. | +3

10

Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody

enthalten in: Clinical chemistry and laboratory medicine | 2020

von Tré-Hardy, M. | Wilmet, A. | Beukinga, I. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]